.After antibody-drug conjugate (ADC) specialist Seagen was actually offered to Pfizer in 2015 for an...
.On the heels of a stage 3 succeed that fell short to make an impression on investors, Ironwood Phar...
.Don't stop Monte Rosa Rehabs currently. The Boston-based biotech is actually having a ball after si...
.Accept to recently's Chutes & Ladders, our roundup of considerable leadership hirings, shootings...
.Commemorating his business's upsized initial public offering (IPO), Septerna chief executive office...
.AbbVie has actually returned to the resource of its antipsychotic powerhouse Vraylar seeking an add...
.GenSight Biologics is weeks out of losing cash. Once again. The biotech simply has enough cash mone...
.Monopar Rehabs is recouping a medicine from the dump of AstraZeneca's uncommon health condition pip...
.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of analysts ...
.After developing a gene therapy relationship with Dyno Therapeutics in 2020, Roche is actually back...